The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Symmetrical Dimethylarginine: A New Combined Parameter for Renal Function and Extent of Coronary Artery Disease
Abstract
Symmetrical dimethylarginine (SDMA) is the structural isomer of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine. Whereas the major route of asymmetric dimethylarginine elimination is the hydrolytic degradation by dimethylarginine dimethylaminohydrolase, SDMA is eliminated by renal excretion. SDMA does not directly inhibit NOS but is a competitor of arginine transport. This study showed for the first time that measurement of SDMA can be a marker of estimated GFR and extent of coronary artery disease (CAD). In 97 patients with CAD, SDMA was a marker of estimated GFR. On multiple regression analysis of the CAD parameter stenosis score, SDMA was the only parameter retained. In addition, endothelial cells from the third passage were cultured in medium that contained 70 micromol/L arginine and was incubated for 24 h in the presence of various concentration of SDMA (0, 2, 5, 10, and 100 micromol/L). The levels of nitrate and nitrite in conditioned media, the protein expression of NOS, and the content of reactive oxygen species in endothelial cells were determined. SDMA inhibited dose dependently the NO synthesis in intact endothelial cells, whereas it had no effect on protein expression of NOS. This effect was associated with an increase in reactive oxygen species. Co-incubation with L-arginine but not D-arginine reversed the effect of SDMA on NOS pathway. Our data suggest that SDMA reduced the endothelial NO synthesis, probably by limiting L-arginine supply to NOS. It is concluded that SDMA might be a useful parameter for detecting patients in very early stages of chronic kidney disease and for determining their risk for developing cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00365.x · Cited by 3,946
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Endogenous Nitric Oxide Synthase Inhibitor: A Novel Marker of Atherosclerosis
Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756
Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine
Stühlinger, M. C., Tsao, P. S., Her, J.-H., Kimoto, M., Balint, R. F., & Cooke, J. P. (2001) · Circulation · doi:10.1161/hc4601.098514 · Cited by 662
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stühlinger, M. C. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine
Valkonen, V.-P., Päivä, H., Salonen, J. T., Lakka, T. A., Lehtimäki, T., Laakso, J., & Laaksonen, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07184-7 · Cited by 562 · cited 1×
“(33) could show that SDMA is elevated in patients with previous coronary events as compared with control subjects without previous coronary heart disease.”
ResultLEIPER, J. M., MARIA, J. S., Chubb, A., MacAllister, R. J., Charles, I. G., Whitley, G., & Vallance, P. J. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430209 · Cited by 478
McDonald, K. K., Zharikov, S., Block, E. R., & Kilberg, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31213 · Cited by 436
Asymmetrical Dimethylarginine: The Über Marker?
Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000126823.07732.d5 · Cited by 396 · cited 4×
“Patients with CKD even in stages 1 through 4 are in the highest risk group for the development of cardiovascular disease (CVD), and, accordingly, recent guidelines and position statements have defined CKD as a CVD equivalent (29).”
BackgroundInfluentialInterference ofL-Arginine Analogues withL-Arginine Transport Mediated by the y+Carrier hCAT-2B
Closs, E. I., Basha, F. Z., Habermeier, A., & Förstermann, U. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0106 · Cited by 385
Ravani, P., Tripepi, G., Malberti, F., Testa, S., Mallamaci, F., & Zoccali, C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010076 · Cited by 381
Kielstein, J. T., Bo[Combining Diaeresis]ger, R. H., Bode-Bo[Combining Diaeresis]ger, S. M., Fro[Combining Diaeresis]lich, J. D. C., Haller, H., Ritz, E., & Fliser, D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131170 · Cited by 369
Self-citationRedox Mechanisms in Blood Vessels
Mueller, C. F. H., Laude, K., McNally, J. S., & Harrison, D. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000149143.04821.eb · Cited by 342
The Clinical Pharmacology of L-Arginine
Böger, R. H., & Bode-Böger, S. M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.79 · Cited by 331
Fliser, D., Kronenberg, F., Kielstein, J. T., Morath, C., Bode-Bo[Combining Diaeresis]ger, S. M., Haller, H., & Ritz, E. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020179 · Cited by 312
Self-citationBode-Böger, S. M., Böger, R. H., Kienke, S., Junker, W., & Frölich, J. C. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0279 · Cited by 304
Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia: Role of Asymmetric Dimethylarginine
Stühlinger, M. C., Oka, R. K., Graf, E. E., Schmölzer, I., Upson, B. M., Kapoor, O., Szuba, A., Malinow, M. R., Wascher, T. C., Pachinger, O., et al. (2003) · Circulation · doi:10.1161/01.cir.0000085067.55901.89 · Cited by 303
Sullivan, D. R., Marwick, T. H., & Freedman, S. B. (1990) · American Heart Journal · doi:10.1016/s0002-8703(05)80173-5 · Cited by 276
Tripepi, G., Mallamaci, F., & Zoccali, C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110972 · Cited by 261
NIJVELDT, R. (2003) · Clinical Nutrition · doi:10.1054/clnu.2002.0613 · Cited by 256
l-arginine transport is increased in macrophages generating nitric oxide
Bogle, R. G., Baydoun, A. R., Pearson, J. D., Moncada, S., & Mann, G. E. (1992) · Biochemical Journal · doi:10.1042/bj2840015 · Cited by 235
Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension
Kielstein, J. T., Bode-Böger, S. M., Hesse, G., Martens-Lobenhoffer, J., Takacs, A., Fliser, D., & Hoeper, M. M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168414.06853.f0 · Cited by 220
Self-citationAsymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects
Kielstein, J. T., Bode-Böger, S. M., Frölich, J. C., Ritz, E., Haller, H., & Fliser, D. (2003) · Circulation · doi:10.1161/01.cir.0000060496.23144.a7 · Cited by 211
Self-citationBÖGER, R. H., LENTZ, S. R., BODE-BÖGER, S. M., KNAPP, H. R., & HAYNES, W. G. (2001) · Clinical Science · doi:10.1042/cs1000161 · Cited by 204
Tojo, A., Welch, W. J., Bremer, V., Kimoto, M., Kimura, K., Omata, M., Ogawa, T., Vallance, P., & Wilcox, C. S. (1997) · Kidney International · doi:10.1038/ki.1997.490 · Cited by 200
PRMT7, a New Protein Arginine Methyltransferase That Synthesizes Symmetric Dimethylarginine
Lee, J.-H., Cook, J. R., Yang, Z.-H., Mirochnitchenko, O., Gunderson, S. I., Felix, A. M., Herth, N., Hoffmann, R., & Pestka, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m405295200 · Cited by 197
Pullamsetti, S., Kiss, L., Ghofrani, H. A., Voswinckel, R., Haredza, P., Klepetko, W., Aigner, C., Fink, L., Muyal, J. P., Weissmann, N., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3223fje · Cited by 176
Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency
Marescau, B., Nagels, G., Possemiers, I., De Broe, M. E., Becaus, I., Billiouw, J.-M., Lornoy, W., & De Deyn, P. P. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90273-0 · Cited by 173
Arginine and Endothelial and Vascular Health
Gornik, H. L., & Creager, M. A. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2880s · Cited by 152
Tsikas, D., Böger, R. H., Bode‐Böger, S. M., Gutzki, F. M., & Frölich, J. C. (1994) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(94)00374-2 · Cited by 129
Yu, X., Li, Y., & Xiong, Y. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00443-9 · Cited by 120
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population
Wanby, P., Teerlink, T., Brudin, L. H., Brattström, L. E., Nilsson, I., Palmqvist, P., & Carlsson, M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.033 · Cited by 117
Martens‐Lobenhoffer, J., & Bode‐Böger, S. M. (2003) · Journal of Chromatography B · doi:10.1016/j.jchromb.2003.09.050 · Cited by 110
Self-citationScalera, F., Kielstein, J. T., Martens‐Lobenhoffer, J., Postel, S. C., Diaeresis]ger, M. T., & Bode‐Böger, S. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090735 · Cited by 107
Self-citationRichard, S., MOREL, M., & Cléroux, P. (2005) · Biochemical Journal · doi:10.1042/bj20040373 · Cited by 103
Asymmetrical dimethylarginine: A novel risk factor for coronary artery disease
Lu, T., Ding, Y., Charng, M., & Lin, S. (2003) · Clinical Cardiology · doi:10.1002/clc.4960261006 · Cited by 81
Martens‐Lobenhoffer, J., Krug, O., & Bode‐Böger, S. M. (2004) · Journal of Mass Spectrometry · doi:10.1002/jms.684 · Cited by 71
Self-citationAsymmetric dimethylarginine (ADMA) and acute vascular events
Valkonen, V.-P., & Laaksonen, R. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.05.020 · Cited by 21
Cited by
Protein arginine methylation: from enigmatic functions to therapeutic targeting
Wu, Q., Schapira, M., Arrowsmith, C. H., & Barsyte-Lovejoy, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00159-8 · Cited by 419
Cortese-Krott, M. M., Koning, A., Kuhnle, G. G. C., Nagy, P., Bianco, C. L., Pasch, A., Wink, D. A., Fukuto, J. M., Jackson, A. A., van Goor, H., et al. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7083 · Cited by 366
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function–a meta-analysis
Kielstein, J. T., Salpeter, S. R., Bode-Boeger, S. M., Cooke, J. P., & Fliser, D. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl292 · Cited by 363
Self-citationBiochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
Vanholder, R., Pletinck, A., Schepers, E., & Glorieux, G. (2018) · Toxins · doi:10.3390/toxins10010033 · Cited by 356
Speer, T., Rohrer, L., Blyszczuk, P., Shroff, R., Kuschnerus, K., Kränkel, N., Kania, G., Zewinger, S., Akhmedov, A., Shi, Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.009 · Cited by 310
Metadata
- Authors
- Bode-Bo[Combining Diaeresis]ger, S. M., Scalera, F., Kielstein, J. T., Martens-Lobenhoffer, J., Breithardt, G. D., Fobker, M., & Reinecke, H.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-04
- Volume
- 17
- Issue
- 4
- Pages
- 1128-1134
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2145802142
- Cited by
- 302
- References
- 42
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.